Literature DB >> 24395566

Differential proteomics of Helicobacter pylori associated with autoimmune atrophic gastritis.

Ombretta Repetto1, Stefania Zanussi2, Mariateresa Casarotto2, Vincenzo Canzonieri3, Paolo De Paoli1, Renato Cannizzaro4, Valli De Re1.   

Abstract

Atrophic autoimmune gastritis (AAG) is a condition of chronic inflammation and atrophy of stomach mucosa, for which development can be partially triggered by the bacterial pathogen Helicobacter pylori (HP). HP can cause a variety of gastric diseases, such as duodenal ulcer (DU) or gastric cancer (GC). In this study, a comparative proteomic approach was used by two-dimensional fluorescence difference gel electrophoresis (DIGE) to identify differentially expressed proteins of HP strains isolated from patients with AAG, to identify markers of HP strain associated with AAG. Proteome profiles of HP isolated from GC or DU were used as a reference to compare proteomic levels. Proteomics analyses revealed 27 differentially expressed spots in AAG-associated HP in comparison with GC, whereas only 9 differential spots were found in AAG-associated HP profiles compared with DU. Proteins were identified after matrix-assisted laser desorption ionization (MALDI)-TOF and peptide mass fingerprinting. Some AAG-HP differential proteins were common between DU- and GC-HP (peroxiredoxin, heat shock protein 70 [HSP70], adenosine 5'-triphosphate [ATP] synthase subunit α, flagellin A). Our results presented here may suggest that comparative proteomes of HP isolated from AAG and DU share more common protein expression than GC and provide subsets of putative AAG-specific upregulated or downregulated proteins that could be proposed as putative markers of AAG-associated HP. Other comparative studies by two-dimensional maps integrated with functional genomics of candidate proteins will undoubtedly contribute to better decipher the biology of AAG-associated HP strains.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24395566      PMCID: PMC3951465          DOI: 10.2119/molmed.2013.00076

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  85 in total

1.  Comparative analysis of colonization of Helicobacter pylori and glycolipids receptor density in Mongolian gerbils and mice.

Authors:  H Osawa; K Sugano; M Iwamori; M Kawakami; M Tada; M Nakao
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

2.  Proteome analysis of secreted proteins of the gastric pathogen Helicobacter pylori.

Authors:  Dirk Bumann; Sevil Aksu; Meike Wendland; Katharina Janek; Uschi Zimny-Arndt; Nicolas Sabarth; Thomas F Meyer; Peter R Jungblut
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

3.  Clustering of clinical strains of Helicobacter pylori analyzed by two-dimensional gel electrophoresis.

Authors:  H Enroth; T Akerlund; A Sillén; L Engstrand
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

4.  Identifying the major proteome components of Helicobacter pylori strain 26695.

Authors:  Myung-Je Cho; Beong-Sam Jeon; Jeong-Won Park; Tae-Sung Jung; Jae-Young Song; Woo-Kon Lee; Yeo-Jeong Choi; Sang-Haeng Choi; Seong-Gyu Park; Jeong-Uck Park; Mi-Young Choe; Seun-Ae Jung; Eun-Young Byun; Seung-Chul Baik; Hee-Shang Youn; Gyung-Hyuck Ko; DongBin Lim; Kwang-Ho Rhee
Journal:  Electrophoresis       Date:  2002-04       Impact factor: 3.535

5.  Proteome analysis of Helicobacter pylori: major proteins of type strain NCTC 11637.

Authors:  R A Lock; S J Cordwell; G W Coombs; B J Walsh; G M Forbes
Journal:  Pathology       Date:  2001-08       Impact factor: 5.306

6.  Relation between cytokines and Helicobacter pylori in gastric cancer.

Authors:  Y Yamaoka; T Kodama; M Kita; J Imanishi; K Kashima; D Y Graham
Journal:  Helicobacter       Date:  2001-06       Impact factor: 5.753

7.  Comparative proteome analysis of Helicobacter pylori.

Authors:  P R Jungblut; D Bumann; G Haas; U Zimny-Arndt; P Holland; S Lamer; F Siejak; A Aebischer; T F Meyer
Journal:  Mol Microbiol       Date:  2000-05       Impact factor: 3.501

8.  Identification of protein vaccine candidates from Helicobacter pylori using a preparative two-dimensional electrophoretic procedure and mass spectrometry.

Authors:  C L Nilsson; T Larsson; E Gustafsson; K A Karlsson; P Davidsson
Journal:  Anal Chem       Date:  2000-05-01       Impact factor: 6.986

Review 9.  Helicobacter pylori: phenotypes, genotypes and virulence genes.

Authors:  José Luiz Proença-Modena; Gustavo Olszanski Acrani; Marcelo Brocchi
Journal:  Future Microbiol       Date:  2009-03       Impact factor: 3.165

10.  Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice.

Authors:  Y Kitadai; Y Takahashi; K Haruma; K Naka; K Sumii; H Yokozaki; W Yasui; N Mukaida; Y Ohmoto; G Kajiyama; I J Fidler; E Tahara
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

View more
  9 in total

1.  A case of mixed adenoneuroendocrine carcinoma of the stomach with focal intestinal metaplasia and hypergastrinemia.

Authors:  Hayato Yamauchi; Shinji Sakurai; Nobuhiro Nakazawa; Tomonori Yoshida; Yuichi Tabe; Kana Saitoh; Takaharu Fukasawa; Shinsuke Kiriyama; Hiroshi Naitoh; Hiroyuki Kuwano
Journal:  Int Surg       Date:  2015-03

2.  Peripheral T-Cell Reactivity to Heat Shock Protein 70 and Its Cofactor GrpE from Tropheryma whipplei Is Reduced in Patients with Classical Whipple's Disease.

Authors:  Lucia Trotta; Kathleen Weigt; Katina Schinnerling; Anika Geelhaar-Karsch; Gerrit Oelkers; Federico Biagi; Gino Roberto Corazza; Kristina Allers; Thomas Schneider; Ulrike Erben; Verena Moos
Journal:  Infect Immun       Date:  2017-07-19       Impact factor: 3.441

3.  Comparative Analysis of Two Helicobacter pylori Strains using Genomics and Mass Spectrometry-Based Proteomics.

Authors:  Roger Karlsson; Kaisa Thorell; Shaghayegh Hosseini; Diarmuid Kenny; Carina Sihlbom; Åsa Sjöling; Anders Karlsson; Intawat Nookaew
Journal:  Front Microbiol       Date:  2016-11-11       Impact factor: 5.640

4.  Protein signature characterizing Helicobacter pylori strains of patients with autoimmune atrophic gastritis, duodenal ulcer and gastric cancer.

Authors:  Valli De Re; Ombretta Repetto; Stefania Zanussi; Mariateresa Casarotto; Laura Caggiari; Vincenzo Canzonieri; Renato Cannizzaro
Journal:  Infect Agent Cancer       Date:  2017-04-27       Impact factor: 2.965

5.  Identification of protein clusters predictive of tumor response in rectal cancer patients receiving neoadjuvant chemo-radiotherapy.

Authors:  Ombretta Repetto; Valli De Re; Antonino De Paoli; Claudio Belluco; Lara Alessandrini; Vincenzo Canzonieri; Renato Cannizzaro
Journal:  Oncotarget       Date:  2017-04-25

6.  Quantitative Proteomic Approach Targeted to Fibrinogen β Chain in Tissue Gastric Carcinoma.

Authors:  Ombretta Repetto; Stefania Maiero; Raffaella Magris; Gianmaria Miolo; Maria Rita Cozzi; Agostino Steffan; Vincenzo Canzonieri; Renato Cannizzaro; Valli De Re
Journal:  Int J Mol Sci       Date:  2018-03-07       Impact factor: 5.923

7.  Polymorphisms in Pepsinogen C and miRNA Genes Associate with High Serum Pepsinogen II in Gastric Cancer Patients.

Authors:  Valli De Re; Mariangela De Zorzi; Laura Caggiari; Ombretta Repetto; Giulia Brisotto; Raffaela Magris; Stefania Zanussi; Agostino Steffan; Renato Cannizzaro
Journal:  Microorganisms       Date:  2021-01-07

8.  Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer.

Authors:  Valli De Re; Enrico Orzes; Vincenzo Canzonieri; Stefania Maiero; Mara Fornasarig; Lara Alessandrini; Silvia Cervo; Agostino Steffan; Giorgio Zanette; Cinzia Mazzon; Paolo De Paoli; Renato Cannizzaro
Journal:  Clin Transl Gastroenterol       Date:  2016-07-21       Impact factor: 4.488

Review 9.  Immunological Aspects of the Tumor Microenvironment and Epithelial-Mesenchymal Transition in Gastric Carcinogenesis.

Authors:  Jacek Baj; Karolina Brzozowska; Alicja Forma; Amr Maani; Elżbieta Sitarz; Piero Portincasa
Journal:  Int J Mol Sci       Date:  2020-04-06       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.